Donation

Donate
Myeloma Minute
Topics
The Phase 2 CARTITUDE-2 Trial: Updated Efficacy and Safety of Ciltacabtagene Autoleucel in Patients with Multiple Myeloma and 1–3 Prior Lines of Therapy (Cohort A) and with Early Relapse after First Line Treatment (Cohort B)

The Phase 2 CARTITUDE-2 Trial: Updated Efficacy and Safety of Ciltacabtagene Autoleucel in Patients with Multiple Myeloma and 1–3 Prior Lines of Therapy (Cohort A) and with Early Relapse after First Line Treatment (Cohort B)

January 8, 2024
ASH
Sequential T-Cell Engagement for Myeloma (“STEM”) Trial: A Phase 2 Study of Cevostamab Consolidation Following BCMA CAR T Cell Therapy

The STEM Trial Phase II Study on Cevostamab Consolidation After BCMA CAR T-Cell Therapy 

January 8, 2024
ASH
BMS-986393 (CC-95266), a G Protein–Coupled Receptor Class C Group 5 Member D (GPRC5D)–Targeted Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory Multiple Myeloma (RRMM): Updated Results from a Phase 1 Study

Updates in Myeloma Treatment: BMS-986393 CAR T-Cell Therapy Shows Promise in Phase I Study for Relapsed/Refractory Patients

January 8, 2024
ASH
Randomized Phase III Study of Pomalidomide Cyclophosphamide Dexamethasone (PCd) Versus Pomalidomide Dexamethasone (Pd) in Relapse or Refractory Myeloma: An Asian Myeloma Network (AMN) Study Presented at ASH 2023

Optimizing Myeloma Treatment: Pomalidomide-based Regimens Compared in Asian Myeloma Network (AMN) Study — a Phase III Analysis of PCd vs. Pd for Relapse or Refractory Myeloma (RRMM)

January 4, 2024
ASH
What is the IMF's iStopMM study?

What is the IMF's iStopMM study?

December 7, 2023
Ask Dr. Durie
How is the Black Swan Research Initiative Approaching Early Myeloma Development? 

How is the Black Swan Research Initiative Approaching Early Myeloma Development?

November 30, 2023
Ask Dr. Durie
Ask Me Anything Replay: Exploring Myeloma Research Breakthroughs with Dr. Joseph Mikhael

Ask Me Anything Replay: Exploring Myeloma Research Breakthroughs with Dr. Joseph Mikhael

October 23, 2023
Facebook Live
living well nutrition 2023 banner

Living Well With Myeloma: Can Nutrition Improve Quality of Life and Outcomes in Myeloma?

October 12, 2023
Living Well with Myeloma
What is the IMWG and what is its purpose in the field of myeloma research?

What is the IMWG and what is its purpose in the field of myeloma research?

October 5, 2023
Ask Dr. Durie
What is the latest from the Black Swan Research Initiative?

What is the latest from the Black Swan Research Initiative?

July 27, 2023
Ask Dr. Durie
ASCO23 Dr. Katja Weisel DREAMM-3

Phase 3, open-label, randomized trial comparing safety and efficacy of belamaf to Pd in RRMM: DREAMM-3 study

July 10, 2023
ASCO/EHA
EHA2023 Dr. Nikhil Munshi on CARTITUDE-1

CARTITUDE-1: Final results of Ciltacabtagene Autoleucel in heavily pretreated relapsed/refractory multiple myeloma

July 7, 2023
ASCO/EHA

Give Where Most Needed

Learn More